EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B

Jade M Katinas iD, Kangsa Amporndanai, Ashley J Taylor, Kristie L Rose, Peter C Gareiss, Roberto A Crespo, Jason Phan, Alex G Waterson, Stephen W Fesik

Protein Science · 2025-12 · 34 (12)

DOI: 10.1002/pro.70365 ↗

At a glance

Journal article in Protein Science, published online on 2025-11-13. Written by Jade M Katinas and 8 co-authors. Institution: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Major MEDLINE topics: Ubiquitin-Protein Ligases, Carrier Proteins, Cell Cycle Proteins. Cited 2 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH HHS, Arvinas, Inc, NIGMS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Targeted protein degradation using PROTACs (PROteolysis TArgeting Chimeras) has emerged as a transformative therapeutic strategy, largely relying on a small number of E3 ubiquitin ligases such as CRBN and VHL. However, resistance, toxicity, and poor oral bioavailability limit the utility of PROTACs and highlight the need to expand the E3 ligase toolbox. Fem‐1 homolog B (FEM1B) is a lesser‐known E3 ligase that offers a promising alternative due to its broad expression and ability to recognize diverse degron motifs. Here, we describe the development of a stable construct of FEM1B, the results of a protein‐observed NMR‐based fragment screen using this construct, and the X‐ray structures of some of the fragment hits when bound to the protein. From these results, new PROTACs utilizing FEM1B as the E3 ligase may be discovered, providing an alternative E3 ligase for targeted protein degradation.

Subjects

MeSH terms (MEDLINE)

Ubiquitin-Protein LigasesCarrier ProteinsCell Cycle ProteinsHumansProteolysisNuclear Magnetic Resonance, BiomolecularCrystallography, X-RayModels, Molecular

Author keywords

1H‐13C‐SOFAST HMQCE3 ligaseFem‐1 homolog B (FEM1B)NMRX‐ray crystal structureconstruct designfragment screen

Substances

Ubiquitin-Protein LigasesCarrier ProteinsCell Cycle Proteins

Authors and institutions

  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Arvinas, Inc., New Haven, Connecticut, USA.
  • Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.

ORCID profiles: Jade M Katinas

Funding

  • NIH HHS
  • Arvinas, Inc
  • NIGMS NIH HHS
  • NCRR NIH HHS

Cite

APA

Katinas, J. M., Amporndanai, K., Taylor, A. J., Rose, K. L., Gareiss, P. C., Crespo, R. A., Phan, J., Waterson, A. G., & Fesik, S. W. (2025). Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science, 34(12). https://doi.org/10.1002/pro.70365

Vancouver

Katinas JM, Amporndanai K, Taylor AJ, Rose KL, Gareiss PC, Crespo RA, et al. Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science. 2025;34(12). doi:10.1002/pro.70365

BibTeX
@article{Katinas2025,
  author = {Katinas, Jade M and Amporndanai, Kangsa and Taylor, Ashley J and Rose, Kristie L and Gareiss, Peter C and Crespo, Roberto A and Phan, Jason and Waterson, Alex G and Fesik, Stephen W},
  title = {Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {12},
  doi = {10.1002/pro.70365}
}
Start for free →